Pediatricians and health officials petitioned the FDA to restrict marketing of cold medicines for children under 6 due to insufficient testing.
Overdoses are common, with some children experiencing medical issues even at recommended doses.
Johnson & Johnson voluntarily recalled infant products to prevent misuse.
The FDA advised against giving cough medicines to children under 2.
Industry leaders withdrew infant cold medicines from the market amid safety concerns.
The FDA is reviewing the safety of these products, emphasizing the need for proper dosing and cautioning against misuse.
